Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1

Oncogene

Volumn 22, Issue 7, 2003, Pages 1024-1034

  Plymate, Stephen R ^a,f   Haugk, Kathy H ^a   Sprenger, Cynthia C ^a   Nelson, Peter S ^a,b   Tennant, Marie K ^a   Zhang, Yuping ^c   Oberley, Larry W ^c   Zhong, Weixiong ^d,e   Drivdahl, Rolf ^a   Oberley, Terry D ^d,e  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cancer; IGFBP rP1; Mac25; Prostate; SOD 2

Indexed keywords

BETA GALACTOSIDASE; COMPLEMENTARY DNA; ERK PROTEIN; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN RELATED PROTEIN 1; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN DERIVATIVE; PROTEIN KINASE B; SOMATOMEDIN BINDING PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CANCER INHIBITION; CELL CYCLE; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; DNA MICROARRAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE TUMOR; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SENESCENCE; TUMOR GROWTH;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOCARCINOMA; ANIMALS; APOPTOSIS; BETA-GALACTOSIDASE; CARRIER PROTEINS; CELL AGING; CELL LINE, TRANSFORMED; CHROMONES; ENZYME INDUCTION; ENZYME INHIBITORS; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROGEN PEROXIDE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHOLINES; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; TRANSFECTION; TUMOR CELLS, CULTURED;

MUS MUSCULUS;

EID: 0037455743     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206210     Document Type: Article

References (35)

1. Bae V, Jackson-Cook C, Brothman A, Maygarden S and Ware J. (1994). Int. J. Cancer, 58, 721-729.
2. Bae V, Jackson-Cook C, Maygarden S, Chen J, Plymate S and Ware J. (1998). Prostate, 34, 275-282.
3. Bae V, Jackson-Cook C, Maygarden S, Edelman W, Brothman A, Chen J and Ware J. (1995). Proc. Amer. Assoc. Cancer Res., Cancer Res., 642 (abstract), 55.
4. Baker A, Oberley L and Cohen M. (1997). Prostate, 32, 229-233.
5. Birkenkamp KV, Dokter WHA, Esselink MT, Jonk LUC, Kruijer W and Vellenga E. (1999). Leukemia, 13, 1037-1045.
6. Birnbaum R, Ware J and Plymate S. (1994). J. Endocrinol., 141, 535-540.
7. Bost F, Caron L, Marchetti I, Dani C and Le Marchand-Brustel Y. (2002). J. Biochem., 361, 621-627.
8. Bostwick D, Alexander E, Singh R, Shan R, Qian J, Santella R, Oberley L, Yan T, Zhong W, Jiang X and Oberley T. (2000). Am. Cancer Soc., 89, 123-134.
9. Chen Q, Bartholomew J, Campisi J, Acosta M, Reagan J and Ames B. (1998). J. Biochem., 332, 43-50.
10. de Haan J, Cristiano F, Iannello R, Bladier C, Kelner M and Kola I. (1996). Hum. Mol. Genet., 5, 283-292.
11. Hawkins V, Doll D, Bumgarner R, Smith T, Abajian C, Hood L and Nelson P. (1999). Nucleic Acids Res., 27(1), 204-208.
12. Huang C, Zhang Z, Ding Z, Li J, Ye J, Leonard S, Shen H-M, Butterworth L, Lu Y, Costa M, Rojanasakul Y, Castranova V, Vallyathan V and Shi X. (2000). J. Biol. Chem., 275, 32516-32522.
13. Hwa V, Oh Y and Rosenfeld R. (1998a). Acta. Ped. Scand., 428, 37-45.
14. Hwa V, Tomasini-Sprenger C, Bermejo A, Rosenfeld R and Plymate S. (1998b). J. Clin. Endocrinol., 83, 4355-4362.
15. Jackson-Cook C, Bae V, Edelman W, Brothman A and Ware J. (1996). Cancer Genet. Cytogen., 87, 14-23.
16. Kim K, Rodriguez A, Carrico P and Melendez J. (2001). Antioxidants Redox Signal., 3, 361-373.
17. Kim H-P, Roe J-H, Chock P and Yim M. (1999). J. Biol. Chem., 274, 37455-37460.
18. Kinscherf R, Claus R, Wagner M, Gehrke C, Kamencic H, Hou D, Nauen O, Schmiedt W, Kovacs G, Pill J, Metz J and Deigner H. (1998). FASEB J., 12, 461-467.
19. Li N, Oberley T, Oberley L and Zhong W. (1998a). J. Cellular Physiol., 175, 359-369.
20. Li N, Oberley T, Oberley L and Zhong W. (1998b). Prostate, 35, 221-223.
21. Lopez-Bermejo A, Buckway C, Devi G, Hwa V, Plymate S, Oh Y and Rosenfeld R. (2000). Endocrinology, 141, 4072-4080.
22. McCord J. (2000). Am. J. Med., 108, 652-659.
23. Oberley L. (2001). Antioxidants Redox Signal., 3, 461-472.
24. Oberley TD and Oberley LW. (1997). Histol. Histophathol., 12, 525-535.
25. Oh Y, Nagalla R, Yamanaka Y, Kim H, Wilson E and Rosenfield R. (1996). J. Biol. Chem., 271, 30322-30325.
26. Plymate S, Ware J, Tennant M, Thrasher J, Chatta K and Birnbaum R. (1996). J. Clin. Endocrinol. Metab, 81, 3709-3716.
27. Pritchard C, Hsu L, Delrow J and Nelson P. (2001). Proc. Natl. Acad. Sci. USA, 98, 13266-13271.
28. Rhee S, Bae Y, Lee S-R and Kwon J. (2000). Science's Signal Transduction Knowledge Environment, www.stke.org/cgi/content/full/OC_sigtrans;2000/53/pe1, pp. 1-4.
29. Sachdeva R, Martin A-M, Heyworth M, Zeigler-Johnson C, Spangler E, Wlker A, Malkowicz S and Rebbeck T. (2001). Am. J. Hum. Genet., 69(4), 261.
30. Sprenger C, Damon S, Hwa V, Rosenfeld R and Plymate S. (1999). Cancer Res., 59, 2370-2375.
31. Sprenger C, Vail M, Evans K, Simurdak J and Plymate S. (2002). Oncogene, 21, 140-147.
32. Wartenberg M, Diedershagen H, Hescheler J and Sauer H. (1999). J. Biol. Chem., 39, 27759-27767.
33. Widmann C, Gerwins P, Johnson N, Jarpe M and Johnsou G. (1998). Mol. Cell. Biol., 18, 2416-2429.
34. Wilson E, Oh Y, Hwa V and Rosenfeld R. (2001). J. Clin. Endocrinol. Metab., 86, 4504-4511.
35. Zhong W and Oberley T. (2001). Cancer Res., 61, 7071-7078.